The European Journal of Contraception and Reproductive HealthCare

The European Journal of Contraception and Reproductive HealthCare An International, peer-reviewed Journal publishing high-quality research about reproductive health.

Multiple sclerosis (MS) onset often coincides with reproductive age, but family planning counselling is not standard in ...
19/12/2024

Multiple sclerosis (MS) onset often coincides with reproductive age, but family planning counselling is not standard in MS care. The detailed perspectives provided here aim to enable health care professionals involved in reproductive life planning to provide informed counselling for people with MS and their partners.

An international Expert panel for a very important topic, just published!

Multiple sclerosis (MS) is often diagnosed in people of reproductive age. However, family planning counselling is not always integrated within MS care. Decisions on family planning can be further c...

We observed changes in the management of women with abnormal uterine bleeding, probably because of an unprepared healthc...
12/12/2024

We observed changes in the management of women with abnormal uterine bleeding, probably because of an unprepared healthcare system and the need to direct resources to the care of COVID-19 patients. A new interesting report from Brazil🇧🇷

To determine practice patterns in the diagnosis and management of nongestational abnormal uterine bleeding (AUB) in women in reproductive years during the SARS-CoV-2 (COVID-19) pandemic in Brazil.A...

The first paper that gives practical real advices for the insertion, removal and management of abnormal uterine bleeding...
06/12/2024

The first paper that gives practical real advices for the insertion, removal and management of abnormal uterine bleeding in users of one of the most used long acting contraceptive methods in the world, the etonogestrel implant... now OPEN ACCESS for everyone, worldwide!

The use of long-acting reversible contraceptives (LARCs) is increasing globally due to their higher ability to effectively prevent unintended pregnancies in comparison to short-acting reversible co...

Happy World Contraception Day 2024!!! 🌈🌎🌍🌏
26/09/2024

Happy World Contraception Day 2024!!! 🌈🌎🌍🌏

03/07/2024

The new Impact Factor for The European Journal of Contraception and Reproductive HealthCare is 1.9, the highest in the history of the Journal!

3.7 (2023) CiteScore (Scopus)
Q2 (2023) CiteScore Best Quartile
0.914 (2023) SNIP
0.735 (2023) SJR

We presented five cases with necrosis at the ENG-implant site of placement in which we proposed an early diagnosis and m...
13/03/2024

We presented five cases with necrosis at the ENG-implant site of placement in which we proposed an early diagnosis and multidisciplinary treatment to avoid severe aesthetic or functional damages.

A very rare side effect of implant placement 🇧🇷 to be discussed!

Implant-site necrosis is a rare complication. We present a case-series of a necrosis as an adverse effect after the etonogestrel (ENG)-subdermal contraceptive implant placement.Five women with site...

Contraception with DRSP 24 + 4 was associated with a non-deteriorating effect on coagulation markers and a significant p...
12/03/2024

Contraception with DRSP 24 + 4 was associated with a non-deteriorating effect on coagulation markers and a significant progressive reduction of days of scheduled and unscheduled bleeding.

The safety of a new progestin-only pill!🇮🇹

Progestin-only pills (POPs), compared to combined, are not associated with an increased risk of venous thromboembolism, but are associated with a poor cycle control. The aim of this study was to ev...

The knowledge and perception of menstruation characteristics among women is inadequate. The results of this study sugges...
12/03/2024

The knowledge and perception of menstruation characteristics among women is inadequate. The results of this study suggested that many gynecological symptoms that can affect women in their later stages of life may be unintentionally ignored.

Talk about MENSTRUAL HEALTH!

To evaluate menstruation characteristics, perceptions, and health-seeking behaviours in women.We conducted this cross-sectional study with 394 women between February 2021 and October 2021. Accordin...

Even though LNG-IUS 52 mg is the first-line treatment for abnormal uterine bleeding, oral hormonal therapies should be e...
12/03/2024

Even though LNG-IUS 52 mg is the first-line treatment for abnormal uterine bleeding, oral hormonal therapies should be effectively managed by gynaecologists in case of contraindications or patient’s decline. Contraceptive pills are practical, but further studies are necessary to compare their efficacy and to approve them with the specific AUB indication.
An Italian review for Abnormal Uterine Bleeding! 🇮🇹

abnormal uterine bleeding is a very frequent reason for referral to gynaecologists and can deeply influence the quality of life. Once organic causes requiring surgical treatment are ruled out, clin...

Adres

Opalfeneweg 3
Ternat
1740

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer The European Journal of Contraception and Reproductive HealthCare nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact

Stuur een bericht naar The European Journal of Contraception and Reproductive HealthCare:

Delen